全文获取类型
收费全文 | 217884篇 |
免费 | 20106篇 |
国内免费 | 9835篇 |
专业分类
耳鼻咽喉 | 2894篇 |
儿科学 | 5093篇 |
妇产科学 | 2771篇 |
基础医学 | 35340篇 |
口腔科学 | 6283篇 |
临床医学 | 17758篇 |
内科学 | 27051篇 |
皮肤病学 | 5038篇 |
神经病学 | 11394篇 |
特种医学 | 6677篇 |
外国民族医学 | 159篇 |
外科学 | 21099篇 |
综合类 | 34983篇 |
现状与发展 | 61篇 |
预防医学 | 5826篇 |
眼科学 | 4017篇 |
药学 | 16351篇 |
65篇 | |
中国医学 | 6683篇 |
肿瘤学 | 38282篇 |
出版年
2024年 | 223篇 |
2023年 | 3020篇 |
2022年 | 4080篇 |
2021年 | 8071篇 |
2020年 | 7145篇 |
2019年 | 6771篇 |
2018年 | 6835篇 |
2017年 | 7372篇 |
2016年 | 7928篇 |
2015年 | 8897篇 |
2014年 | 13103篇 |
2013年 | 14178篇 |
2012年 | 12423篇 |
2011年 | 13876篇 |
2010年 | 11452篇 |
2009年 | 11156篇 |
2008年 | 11622篇 |
2007年 | 11981篇 |
2006年 | 10942篇 |
2005年 | 9958篇 |
2004年 | 8735篇 |
2003年 | 7541篇 |
2002年 | 6376篇 |
2001年 | 5549篇 |
2000年 | 4565篇 |
1999年 | 4120篇 |
1998年 | 3779篇 |
1997年 | 3474篇 |
1996年 | 2690篇 |
1995年 | 2726篇 |
1994年 | 2398篇 |
1993年 | 1955篇 |
1992年 | 1596篇 |
1991年 | 1478篇 |
1990年 | 1141篇 |
1989年 | 1068篇 |
1988年 | 1000篇 |
1987年 | 816篇 |
1986年 | 724篇 |
1985年 | 954篇 |
1984年 | 862篇 |
1983年 | 583篇 |
1982年 | 637篇 |
1981年 | 510篇 |
1980年 | 416篇 |
1979年 | 338篇 |
1978年 | 230篇 |
1977年 | 182篇 |
1976年 | 138篇 |
1975年 | 52篇 |
排序方式: 共有10000条查询结果,搜索用时 26 毫秒
131.
Deoxynivalenol (DON) has broad toxicity in animals and humans. In this study the impact of DON treatment on apoptotic pathways in PC12 cells was determined. The effects of DON were evaluated on (i) typical indicators of apoptosis, including cellular morphology, cell activity, lactate dehydrogenase (LDH) release, and apoptosis ratio in PC12 cells, and on (ii) the expression of key genes and proteins related to apoptosis, including Bcl-2, Bax, Bid, cytochrome C (Cyt C), apoptosis inducing factor (AIF), cleaved-Caspase9, and cleaved-Caspase3. DON treatment inhibited proliferation of PC12 cells, induced significant morphological changes and apoptosis, promoted the release of Cyt C and AIF from the mitochondria, and increased the activities of cleaved-Caspase9 and cleaved-Caspase3. Bcl-2 expression decreased with increasing DON concentrations, in contrast to Bax and Bid, which were increased with increasing DON concentration. These data demonstrate that DON induces apoptosis in PC12 cells through the mitochondrial apoptosis pathway. 相似文献
132.
133.
134.
《Clinical genitourinary cancer》2020,18(2):88-94.e2
Recent meta-analyses on checkpoint inhibitors in cancer report conflicting data regarding the association of patient gender with inhibitor efficacy. In advanced kidney cancer, checkpoint inhibitors have shown improved outcomes in first- and second-line settings compared with standard of care, but the role of patient gender on treatment outcome is unclear. We aimed to assess the efficacy of immunotherapy according to patient gender in advanced kidney cancer.We performed a systematic review and meta-analysis according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was performed using PubMed, Scopus, Web of Science, and The Cochrane Library to identify eligible studies published through February 16, 2019. Studies were included if they reported on the differential outcomes of male and female patients with metastatic kidney cancer receiving immunotherapy. Our outcomes of interest were overall survival (OS) or progression-free survival (PFS).Four randomized controlled trials comprising a total of 3664 patients (2715 males and 949 females) met our inclusion criteria. Both men and women with metastatic kidney cancer had an OS and PFS advantage with immunotherapy compared with standard-of-care, but no statistically significant difference between the genders was observed (OS hazard ratio [HR] for men, 0.69; 95% confidence interval [CI], 0.59-0.8; P = .40; HR for women, 0.62; 95% CI, 0.48-0.81; P = .13; PFS HR for men, 0.7; 95% CI, 0.59-0.82; P = .24; HR for women, 0.68; 95% CI, 0.52-0.90; P = .105).In patients with advanced kidney cancer receiving checkpoint inhibitors, there seems to be no association of patient gender with treatment outcome. 相似文献
135.
《Neuro-Chirurgie》2022,68(2):196-201
BackgroundTumor-to-tumor metastases are extremely rarely reported lesions, which usually involve an indolent lesion hosting a more aggressive neoplasm. We present an unusual initial manifestation of a previously unknown clear cell renal cell carcinoma as a tumor-to-tumor metastasis in a typical meningothelial meningioma.Case reportA 73-year old patient with transient left slight monoparesis was addressed to our Neurosurgical Department after being evaluated by his general practitioner and passing a cerebral MRI which revealed a right frontotemporal mass attached to the meninge. At presentation, no deficits were identified; therefore an elective surgery was proposed. Histological analysis revealed a typical meningothelial meningioma containing a metastatic clear cell renal cell carcinoma. Additional thoraco-abdominal computer tomography identified a 6 cm diameter lesion within the right kidney with radiological features highly suggestive of a primary clear cell renal cell carcinoma.ConclusionOur case highlights the need for a specialized neuropathological approach to clinical and imagistic indolent meningiomas, as they may require important differential diagnosis that can highly impact the treatment and follow-up of brain tumor patients. 相似文献
136.
I Ahmad 《Annals of the Royal College of Surgeons of England》2015,97(7):481-486
Urothelial cell carcinoma (UCC) of the bladder is one of the most common malignancies, causing considerable morbidity and mortality worldwide. It is unique among the epithelial carcinomas as two distinct pathways to tumourigenesis appear to exist: low grade, recurring papillary tumours usually contain oncogenic mutations in FGFR3 or HRAS whereas high grade, muscle invasive tumours with metastatic potential generally have defects in the pathways controlled by the tumour suppressors p53 and retinoblastoma. Over the last two decades, a number of transgenic mouse models of UCC, containing deletions or mutations of key tumour suppressor genes or oncogenes, have helped us understand the mechanisms behind tumour development. In this summary, I present my work investigating the role of the WNT signalling cascade in UCC. 相似文献
137.
138.
139.
Birt‐Hogg‐Dubé (BHD) syndrome is associated with the development of hereditary renal cell carcinoma (RCC) and is caused by a germline mutation in the folliculin gene. Most cases of BHD syndrome‐associated RCC (BHD‐RCC) are less aggressive than sporadic clear cell RCC and multifocal. Therefore, it is critical to distinguish BHD‐RCC from its sporadic counterparts to identify and monitor affected families and to preserve renal function for as long as possible. The World Health Organization/International Society of Urological Pathology consensus classification defined distinct entities for certain hereditary RCC; however, BHD‐RCC was not included in this classification. Although the clinical features and molecular mechanisms of BHD‐RCC have been investigated intensively over the last two decades, pathologists and urologists occasionally face difficulties in the diagnosis of BHD‐RCC that require genetic testing. Affected patients usually have miscellaneous benign disorders that often precede renal carcinogenesis. In the present review, we summarize the current understanding of the histopathological features of BHD‐RCC based on our epidemiological studies of Japanese families and a literature review. Pathological diagnostic clues and differential diagnosis of BHD‐RCC from other hereditary RCC are also briefly discussed. 相似文献
140.